Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas

scientific article published in February 2002

Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID11830532

P2093author name stringG Yancey Gillespie
C Ryan Miller
Donald J Buchsbaum
Christopher R Williams
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectcytosineQ178425
gene therapyQ213901
fluorouracilQ238512
P304page(s)773-780
P577publication date2002-02-01
P1433published inCancer ResearchQ326097
P1476titleIntratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas
P478volume62

Reverse relations

cites work (P2860)
Q35537301Adenoviral-mediated imaging of gene transfer using a somatostatin receptor-cytosine deaminase fusion protein
Q36609637Adenovirus-mediated hypoxia-targeting cytosine deaminase gene therapy enhances radiotherapy in tumour xenografts
Q38660825All-Atom MD Predicts Magnesium-Induced Hairpin in Chemically Perturbed RNA Analog of F10 Therapeutic.
Q37251338Antitumor therapy mediated by 5-fluorocytosine and a recombinant fusion protein containing TSG-6 hyaluronan binding domain and yeast cytosine deaminase
Q36474463Bifunctional chimeric SuperCD suicide gene -YCD: YUPRT fusion is highly effective in a rat hepatoma model
Q35696378Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vector
Q48229251Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastoma.
Q42785240Comparative pharmacokinetics of 14C-sucrose in RG-2 rat gliomas after intravenous and convection-enhanced delivery
Q27026937Contemporary murine models in preclinical astrocytoma drug development
Q30545759Cooperativity between MAPK and PI3K signaling activation is required for glioblastoma pathogenesis
Q36220635Design and selection of Toca 511 for clinical use: modified retroviral replicating vector with improved stability and gene expression
Q64984612Dual Functionalized 5-Fluorouracil Liposomes as Highly Efficient Nanomedicine for Glioblastoma Treatment as Assessed in an In Vitro Brain Tumor Model.
Q42135456Gene- and viral-based therapies for brain tumors
Q50905634In Vitro Synergistic Enhancement of Newcastle Disease Virus to 5-Fluorouracil Cytotoxicity against Tumor Cells.
Q35115061Increased sensitivity of glioma cells to 5-fluorocytosine following photo-chemical internalization enhanced nonviral transfection of the cytosine deaminase suicide gene
Q39431566Interaction of endothelial progenitor cells expressing cytosine deaminase in tumor tissues and 5-fluorocytosine administration suppresses growth of 5-fluorouracil-sensitive liver cancer in mice.
Q40413196Interferons upregulate thymidine phosphorylase expression via JAK-STAT-dependent transcriptional activation and mRNA stabilization in human glioblastoma cells
Q40305636Isolation of drug delivery from drug effect: problems of optimizing drug delivery parameters
Q91663805Learning a Latent Space of Highly Multidimensional Cancer Data
Q38893603Magnetic nanoparticle hyperthermia induced cytosine deaminase expression in microencapsulated E. coli for enzyme-prodrug therapy
Q38963855Modeling astrocytoma pathogenesis in vitro and in vivo using cortical astrocytes or neural stem cells from conditional, genetically engineered mice
Q33985663Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders
Q27006099Novel delivery strategies for glioblastoma
Q35077747Oncolytic adenoviruses: A thorny path to glioma cure
Q90420565Photochemical Internalization Enhanced Nonviral Suicide Gene Therapy
Q34389909Photochemical internalization-mediated nonviral gene transfection: polyamine core-shell nanoparticles as gene carrier
Q36297034Photodynamic therapy enhances the efficacy of gene-directed enzyme prodrug therapy
Q24792836Prodrugs for Gene-Directed Enzyme-Prodrug Therapy (Suicide Gene Therapy)
Q36602123Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-Fluorouracil-Mediated Cytotoxicity in Multiple Human Cancer Types
Q37526280Selective anti-tumor activity of the novel fluoropyrimidine polymer F10 towards G48a orthotopic GBM tumors
Q37192753Selective delivery of a therapeutic gene for treatment of head and neck squamous cell carcinoma using human neural stem cells
Q36493746Targeted antitumor prodrug therapy using CNGRC-yCD fusion protein in combination with 5-fluorocytosine
Q34468009Targeted enzyme prodrug therapy for metastatic prostate cancer - a comparative study of L-methioninase, purine nucleoside phosphorylase, and cytosine deaminase
Q36527593The art of gene therapy for glioma: a review of the challenging road to the bedside
Q36640056Therapeutic potential of stem cells expressing suicide genes that selectively target human breast cancer cells: evidence that they exert tumoricidal effects via tumor tropism (review).
Q40760304Toca 511 plus 5-fluorocytosine in combination with lomustine shows chemotoxic and immunotherapeutic activity with no additive toxicity in rodent glioblastoma models

Search more.